Hamburg suggests fees for oversight of drug compounders

03/25/2013 | Reuters · OutpatientSurgery.net

FDA Commissioner Dr. Margaret Hamburg said in a post on her agency's blog Friday that compounding pharmacies should pay fees for the FDA oversight needed to prevent a recent meningitis outbreak from happening again. Hamburg is hoping that the Senate committee in control of the issue "will yield strong legislation for patients across the nation" as serious problems persist in compounding pharmacies. Congress could use registration or other kinds of fees to finance additional oversight, Hamburg said.

View Full Article in:

Reuters · OutpatientSurgery.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA